US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 4.900
  • 0.0000.00%
Trading Mar 20 10:46 ET
221.57MMarket Cap-7.31P/E (TTM)

Y-mAbs Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
3.38%87.69M
13.41%26.5M
-9.74%18.46M
9.86%22.8M
-1.58%19.93M
29.96%84.82M
-25.71%23.36M
63.15%20.45M
92.19%20.75M
93.12%20.25M
Operating revenue
3.38%87.69M
13.41%26.5M
-9.74%18.46M
9.86%22.8M
-1.58%19.93M
29.96%84.82M
-25.71%23.36M
63.15%20.45M
92.19%20.75M
93.12%20.25M
Cost of revenue
33.59%15.25M
284.60%7.84M
-15.01%2.25M
-35.17%3.01M
3.07%2.15M
50.87%11.42M
0.94%2.04M
6.87%2.65M
274.92%4.65M
13.76%2.08M
Gross profit
-1.32%72.43M
-12.53%18.65M
-8.96%16.21M
22.87%19.78M
-2.11%17.78M
27.21%73.4M
-27.54%21.32M
76.99%17.81M
68.48%16.1M
109.91%18.17M
Operating expense
4.60%103.64M
0.27%24.59M
-3.04%24.78M
26.79%29.57M
-3.81%24.69M
-35.04%99.08M
-19.81%24.52M
-29.16%25.56M
-52.88%23.33M
-29.38%25.67M
Selling and administrative expenses
21.82%54.65M
11.14%12.38M
33.46%13.61M
52.90%17.23M
-6.74%11.43M
-26.39%44.86M
3.17%11.14M
-25.14%10.2M
-51.17%11.27M
-8.83%12.25M
Research and development costs
-9.64%48.99M
-8.77%12.21M
-27.28%11.17M
2.37%12.34M
-1.13%13.27M
-40.79%54.22M
-32.34%13.39M
-31.60%15.36M
-54.37%12.06M
-41.44%13.42M
Operating profit
-21.54%-31.2M
-85.56%-5.94M
-10.57%-8.57M
-35.53%-9.79M
7.91%-6.91M
72.92%-25.67M
-177.45%-3.2M
70.22%-7.75M
81.92%-7.22M
72.92%-7.5M
Net non-operating interest income expense
-71.10%1.39M
-166.75%-1.61M
913.76%1.92M
-41.82%640K
-60.49%439K
734.87%4.81M
4.16%2.41M
112.52%189K
192.75%1.1M
397.86%1.11M
Non-operating interest income
-71.10%1.39M
-166.75%-1.61M
913.76%1.92M
-41.82%640K
-60.49%439K
--4.81M
--2.41M
--189K
--1.1M
--1.11M
Other net income (expense)
Income before tax
-42.87%-29.81M
-851.07%-7.54M
12.01%-6.65M
-49.42%-9.15M
-1.24%-6.47M
78.17%-20.87M
-168.54%-793K
72.54%-7.56M
85.11%-6.12M
77.23%-6.39M
Income tax
-126.02%-146K
-485.64%-752K
85.03%346K
-44.13%100K
160K
561K
195K
187K
179K
0
Net income
-38.45%-29.67M
-587.25%-6.79M
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
Net income continuous Operations
-38.45%-29.67M
-587.25%-6.79M
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
Minority interest income
Net income attributable to the parent company
-38.45%-29.67M
-587.25%-6.79M
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.45%-29.67M
-587.25%-6.79M
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
Basic earnings per share
-36.73%-0.67
-650.00%-0.15
11.11%-0.16
-50.00%-0.21
0.00%-0.15
77.63%-0.49
-166.67%-0.02
71.43%-0.18
85.11%-0.14
76.56%-0.15
Diluted earnings per share
-36.73%-0.67
-650.00%-0.15
11.11%-0.16
-50.00%-0.21
0.00%-0.15
77.63%-0.49
-166.67%-0.02
71.43%-0.18
85.11%-0.14
76.56%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 3.38%87.69M13.41%26.5M-9.74%18.46M9.86%22.8M-1.58%19.93M29.96%84.82M-25.71%23.36M63.15%20.45M92.19%20.75M93.12%20.25M
Operating revenue 3.38%87.69M13.41%26.5M-9.74%18.46M9.86%22.8M-1.58%19.93M29.96%84.82M-25.71%23.36M63.15%20.45M92.19%20.75M93.12%20.25M
Cost of revenue 33.59%15.25M284.60%7.84M-15.01%2.25M-35.17%3.01M3.07%2.15M50.87%11.42M0.94%2.04M6.87%2.65M274.92%4.65M13.76%2.08M
Gross profit -1.32%72.43M-12.53%18.65M-8.96%16.21M22.87%19.78M-2.11%17.78M27.21%73.4M-27.54%21.32M76.99%17.81M68.48%16.1M109.91%18.17M
Operating expense 4.60%103.64M0.27%24.59M-3.04%24.78M26.79%29.57M-3.81%24.69M-35.04%99.08M-19.81%24.52M-29.16%25.56M-52.88%23.33M-29.38%25.67M
Selling and administrative expenses 21.82%54.65M11.14%12.38M33.46%13.61M52.90%17.23M-6.74%11.43M-26.39%44.86M3.17%11.14M-25.14%10.2M-51.17%11.27M-8.83%12.25M
Research and development costs -9.64%48.99M-8.77%12.21M-27.28%11.17M2.37%12.34M-1.13%13.27M-40.79%54.22M-32.34%13.39M-31.60%15.36M-54.37%12.06M-41.44%13.42M
Operating profit -21.54%-31.2M-85.56%-5.94M-10.57%-8.57M-35.53%-9.79M7.91%-6.91M72.92%-25.67M-177.45%-3.2M70.22%-7.75M81.92%-7.22M72.92%-7.5M
Net non-operating interest income expense -71.10%1.39M-166.75%-1.61M913.76%1.92M-41.82%640K-60.49%439K734.87%4.81M4.16%2.41M112.52%189K192.75%1.1M397.86%1.11M
Non-operating interest income -71.10%1.39M-166.75%-1.61M913.76%1.92M-41.82%640K-60.49%439K--4.81M--2.41M--189K--1.1M--1.11M
Other net income (expense)
Income before tax -42.87%-29.81M-851.07%-7.54M12.01%-6.65M-49.42%-9.15M-1.24%-6.47M78.17%-20.87M-168.54%-793K72.54%-7.56M85.11%-6.12M77.23%-6.39M
Income tax -126.02%-146K-485.64%-752K85.03%346K-44.13%100K160K561K195K187K179K0
Net income -38.45%-29.67M-587.25%-6.79M9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M
Net income continuous Operations -38.45%-29.67M-587.25%-6.79M9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M
Minority interest income
Net income attributable to the parent company -38.45%-29.67M-587.25%-6.79M9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.45%-29.67M-587.25%-6.79M9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M
Basic earnings per share -36.73%-0.67-650.00%-0.1511.11%-0.16-50.00%-0.210.00%-0.1577.63%-0.49-166.67%-0.0271.43%-0.1885.11%-0.1476.56%-0.15
Diluted earnings per share -36.73%-0.67-650.00%-0.1511.11%-0.16-50.00%-0.210.00%-0.1577.63%-0.49-166.67%-0.0271.43%-0.1885.11%-0.1476.56%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More